III. Proton-therapytherapy. Rome SB - 5/5 1

Similar documents
PROGRESS IN HADRONTHERAPY

SCIENTIFIC AND TECHNOLOGICAL DEVELOPMENT OF HADRONTHERAPY

Heavy Ion Tumor Therapy

Introduction to Ion Beam Cancer Therapy

A brief presentation of The TERA Foundation

ACCELERATORS FOR HADRONTHERAPY

COMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE

Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning

HEAVY PARTICLE THERAPY

Cancer Treatment by Charged Particles - Carbon Ion Radiotherapy -

Progress of Heavy Ion Therapy

Proton and heavy ion radiotherapy: Effect of LET

The Advantages of Particle Therapy and the Status of the Heidelberg Iontherapy Center

Neutrons. ρ σ. where. Neutrons act like photons in the sense that they are attenuated as. Unlike photons, neutrons interact via the strong interaction

Review of Hadron machines for cancer therapy

Proton Treatment. Keith Brown, Ph.D., CHP. Associate Director, Radiation Safety University of Pennsylvania

CERN: from particle physics to medical applications. Manuela Cirilli CERN Knowledge Transfer Life Sciences Section

ADVANCES IN RADIATION TECHNOLOGIES IN THE TREATMENT OF CANCER

OPERATION AND PATIENT TREATMENTS AT CNAO FACILITY

New Treatment Research Facility Project at HIMAC

HADRONTHERAPY: a new frontier for cancer treatment

Ion Beam Therapy should we prioritise research on helium beams?

Review of Heavy Ion Accelerators for Hadrontherapy

A Facility for Tumour Hadron Therapy and Biomedical Research in South-Eastern Europe

Status of H 1 and C 12

Peak temperature ratio of TLD glow curves to investigate the spatial variation of LET in a clinical proton beam

Today, I will present the second of the two lectures on neutron interactions.

Radiotherapy. Marta Anguiano Millán. Departamento de Física Atómica, Molecular y Nuclear Facultad de Ciencias. Universidad de Granada

Neutron Radiotherapy: Past, Present, and Future Directions

Neutron Interactions Part 2. Neutron shielding. Neutron shielding. George Starkschall, Ph.D. Department of Radiation Physics

Radiation qualities in carbon-ion radiotherapy at NIRS/HIMAC

Hampton University Proton Therapy Institute

Chapter Introduction

Hypofractionation in particle therapy. Marco Durante

SUMITOMO Particle Therapy Technologies

An Introduction to Cancer Therapy With Hadron Radiation

Tumor Therapy with Heavy Ions at GSI Darmstadt

Sarcoma and Radiation Therapy. Gabrielle M Kane MB BCh EdD FRCPC Muir Professorship in Radiation Oncology University of Washington

Workshop on Hadron Beam Therapy of Cancer Erice, Sicily April 24-May

PHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015)

Nuclear Data for Radiation Therapy

Biological Optimization of Hadrontherapy. Uwe Oelfke

By Elizabeth Clements. Applications in cancer treatment

The Heidelberg Ion Therapy Center. Thomas Haberer Heidelberg Ion Therapy Center Hadron Therapy Workshop, Erice 2009

Status of Proton Therapy: results and future trends

Topics covered 7/21/2014. Radiation Dosimetry for Proton Therapy

Therapeutic Medical Physics. Stephen J. Amadon Jr., Ph.D., DABR

Radiation physics and radiation protection. University of Szeged Department of Nuclear Medicine

Activities at the Heidelberg Ion Therapy Center (HIT)

MEDICAL PHYSICS ASPECTS OF PARTICLE THERAPY Oliver Jäkel 1,2, *

Nuclear Physics in Proton Radiotherapy

Dosimetric characterization with 62 MeV protons of a silicon segmented detector for 2D dose verifications in radiotherapy

IMPT with Carbon Ions

*Chien-Yi Yeh, Ji-Hong Hong * 葉健一洪志宏

The Heidelberg Ion Therapy Center and PARTNER. Thomas Haberer Heidelberg Ion Therapy Center

Prof. Dr. Thomas Haberer Scientific-technical Director Heidelberg Iontherapy Center

Option D: Medicinal Chemistry

Modelling the induction of cell death and chromosome damage by therapeutic protons

Status of Hadrontherapy facilities worldwide

Recent advances in dosimetry in reference conditions for proton and light-ion beams

Present status and future of Proton beam therapy

Cancer situation as presented by (EC 1991)

Uncertainties in proton therapy: Analysis of the effects of density changes, calibration curve errors and setup errors in proton dose distributions.

Radiobiology for particle therapy

A review of cyclotrons for Hadron Therapy. Y. Jongen Cyclotrons 2010 Lanzhou, September

Basic Press Information

Proton Therapy Dosimetry & Clinical Implementation. Baldev Patyal, Ph.D., Chief Medical Physicist Department of Radiation Medicine

ACCELERATOR DESIGN ISSUES IN CANCER THERAPY

Proton and helium beams: the present and the future of light ion beam therapy

Hadrons on Malignant Cells: Recent Activities within Collaboration between LNS INFN and Vinca Institute of Nuclear Sciences

THE HIGH-CURRENT DEUTERON ACCELERATOR FOR THE NEUTRON THERAPY. S.V. Akulinichev, A. V. Andreev, V.M. Skorkin

Dosimetric characterization with 62 MeV protons of a silicon segmented detector for 2D dose verifications in radiotherapy

PRINCIPLES and PRACTICE of RADIATION ONCOLOGY. Matthew B. Podgorsak, PhD, FAAPM Department of Radiation Oncology

Your co-operation partner for research. EUROPEAN UNION European Regional Development Fund

Particle Therapy- Why?

ABSTRACTS. of the NIRS International Seminar on the Heavy Charged Particle Therapy for Cancer and the XXVII PTCOG MEETING.

Applications of Particle Accelerators

AMERICAN BRAIN TUMOR ASSOCIATION. Proton Therapy

Particle Radiation Therapy. Sophi Farid Phys 3305 Southern Methodist University Spring 2016

NUCLEAR PHYSICS FOR MEDICINE - HADRON THERAPY. Pawel Olko Institute of Nuclear Physics Krakow Poland

HEALTH RISKS FROM EXPOSURE TO FAST NEUTRONS. Prof. Marco Durante

Multi-Ion Analysis of RBE using the Microdosimetric Kinetic Model

Lecture 13 Radiation Onclolgy

TERA PROGRAMME: MEDICAL APPLICATIONS OF PROTONS AND IONS

Road Map for the development of hadron therapy and associated nuclear medicine methods at JINR:

Advances in external beam radiotherapy

HIMAC AND MEDICAL ACCELERATOR PROJECTS IN JAPAN

V. 4. Design and Benchmark Experiment for Cyclotron-based Neutron Source for BNCT

Venue: IEEE NSS/MIC/RTSD Conference, Seoul, South Korea, 27 th October 2013 Workshop: NWK3/RD1 Radiation Protection and Dosimetry

Medical Use of Radioisotopes

Progress in Reactor and Accelerator Based BNCT at Kyoto University Research Reactor Institute

Use of Bubble Detectors to Characterize Neutron Dose Distribution in a Radiotherapy Treatment Room used for IMRT treatments

Intensity Modulated RadioTherapy

Radiation protection in proton therapy

Particle Therapy Systems by Mitsubishi Electric DG1101-KM-0034

Radiation Exposure and Image Quality in X-Ray Diagnostic Radiology

The impact of different radiation qualities on cancer cells

A fast Monte Carlo toolkit on GPU for treatment plan dose recalculation in proton therapy

Clinical Results of Carbon Ion Radiotherapy: The Heidelberg Experience

Transcription:

Outline Introduction: an historical review I Applications in medical diagnostics Particle accelerators for medicine Applications in conventional radiation therapy II III IV Hadrontherapy, the frontier of cancer radiation therapy Proton-therapytherapy Carbon ion therapy Neutrons in cancer therapy V Rome - 14-15.06.07 - SB - 5/5 1

Hadrontherapy with beams of protons and ions Rome - 14-15.06.07 - SB - 5/5 2

Charged particles in matter The Bethe-Bloch Bloch formula: = = 0.3071 MeV / (g/cm 2 ) dx expressed in g/cm 2 Notes: Ionization + eccitation MIP = Minimum Ionizing Particle MIP in water 2.0 MeV/cm 0.2 ev/nm very low LET radiation! Rome - 14-15.06.07 - SB - 5/5 3

The basic concept of hadrontherapy Fundamental physics Particle identification L3 at LEP Medical applications Cancer hadrontherapy Rome - 14-15.06.07 - SB - 5/5 4

The Bragg peak Straggling and multiple scattering Fragmentation Rome - 14-15.06.07 - SB - 5/5 5

Single beam comparison X rays Protons or Carbon ions Rome - 14-15.06.07 - SB - 5/5 6

Protons and ions are more precise than X X--rays Tumour between the eyes 9 X ray beams Rome - 14-15.06.07 - SB - 5/5 1 proton beam 7

The first idea Bob Wilson, 1946 Bob Wilson was student of Lawrence in Berkley Study of the shielding for the new cyclotron Interdisciplinary i environment = new ideas! Use of protons and charged hadrons to better distribute the dose of radiation in cancer therapy R.R. Wilson, Radiology, 47 (1946) 487 Rome - 14-15.06.07 - SB - 5/5 8

The beginning of hadrontherpay 1954 at Berkeley C.A. Tobias, J.H. Lawrence et al., Cancer Research 18 (1958) 121 Rome - 14-15.06.07 - SB - 5/5 9

The basic principles of hadrontherapy Protons 200 MeV 1nA 27 cm Tumour targett Carbon ions 4800 MeV 0.1 na Beam of hadrons which slow down in matter Bragg peak Better conformity of the dose to the target t healthy tissue sparing Hadrons are charged Beam scanning for dose distribution Heavy ions Higher biological effectiveness Rome - 14-15.06.07 - SB - 5/5 10

Energy and current Why 200 MeV protons and 400 MeV/u C ions? Range in water: 200 MeV p 27 cm penetration depth 4800 MeV C ions 27 cm penetration depth Why 1 na current? Requirement: 2 Gy per Kg per minute (2 J / 200 MeV) x (e) x (1/60 sec) 1 na Rome - 14-15.06.07 - SB - 5/5 11

Why ions have a large biological effectiveness? X RBE = 1 RBE = 3 quantum Break of a single/double helix of DNA carbon ion 40 mm from the end of the range electron ionization Multiple breaks of both helixes cannot tbe repaired cromosome Ions have high LET (Linear Energy Transfer) Rome - 14-15.06.07 - SB - 5/5 12

The eye melanoma treatment at INFN-LNS in Catania LNS Supercoducting cyclotron 65 MeV protons 92 patients (oct 2005) Rome - 14-15.06.07 - SB - 5/5 13

First hospital-based proton-therapy therapy centre, built in 1993 ~160/sessions a day ~1000 patients/year The Loma Linda University Medical Center (USA) Rome - 14-15.06.07 - SB - 5/5 14

Dose distribution: passive spreading Double scattering Layer stacking Rome - 14-15.06.07 - SB - 5/5 15

Standard procedure: Passive beam spreading with respiratory gating Double scatterer Collimator Bolus: has to be machined for each case. Rome - 14-15.06.07 - SB - 5/5 16

Advanced procedure: layer stacking with respiratory gating Collimator adapted to transverse shape of each slice. Rome - 14-15.06.07 - SB - 5/5 17

Passive spreading: the nozzle Ionization chamber Propeller Quadrant ionization chamber Beam Rome - 14-15.06.07 - SB - 5/5 18

Passive spreading: calibration before treatment Collimator Bolus Water equivalent absorber Ionization chamber Rome - 14-15.06.07 - SB - 5/5 19

Passive spreading: personalized devices Propeller Collimator Bolus - prostate Bolus - liver Rome - 14-15.06.07 - SB - 5/5 20

Dose distribution: active scanning Longitudinal plane Transverse plane patient fast slow beam horizontal scanning vertical scanning beam tumour volume energy variation New technique developed mainly at GSI and PSI Rome - 14-15.06.07 - SB - 5/5 21

Active spot scanning a la PSI 1 2 Single spot Lateral scanning with magnet: 2 ms/step 3 4 Depth scanning with upstream absorbers Depth scanning Third scanning by a bending magnet and movable bed Rome - 14-15.06.07 - SB - 5/5 22

High precision RT with proton beams Rome - 14-15.06.07 - SB - 5/5 23

High precision RT with proton beams Rome - 14-15.06.07 - SB - 5/5 24

High precision RT with proton beams Rome - 14-15.06.07 - SB - 5/5 25

30 50 100 High precision RT with proton beams Rome - 14-15.06.07 - SB - 5/5 26

Front-end boards A detector for spot scanning: The strip chamber developed by TERA for PSI Mylar window Mylar window U Anode In collaboration with University and INFN Torino 2-sided aluminized cathode T Anode Rome - 14-15.06.07 - SB - 5/5 27

Beam tests on Gantry1 at PSI SAMBA Strip Accurate Monitor for Beam Applications Measurement of a spot Rome - 14-15.06.07 - SB - 5/5 28

Time profile of the clinical beams Tota al Intensit ty SPOTS Average flat top current 0.2 na Time 5 ms Rome - 14-15.06.07 - SB - 5/5 29

A line of dose made of spots Rome - 14-15.06.07 - SB - 5/5 30

Number of potential patients Study by AIRO, 2003 Italian Association for Oncological Radiotharapy X-ray therapy every 10 million inhabitants: 20'000 000 pts/year Protontherapy 14.5% of X-ray patients = 2'900 pts/year Therapy with Carbon ions for radio-resistant resistant tumours 3% of X-ray patients = 600 pts/year Every 50 M inhabitants Proton-therapytherapy 4-5 centres Carbon ion therapy 1 centre TOTAL about 3'500 pts/year every 10 M Rome - 14-15.06.07 - SB - 5/5 31

The sites Up to present Proton-therapy: therapy: ~ 45 000 patients Carbon ion therapy: ~ 2 200 patients t Rome - 14-15.06.07 - SB - 5/5 32

Tumours of the central nervous system Control at 5 years RT Protons ----------------------------------------------------------------- Chordomas 17-50% 73-83% Chondrosarcomas 50-60% 90-98% 98% Rome - 14-15.06.07 - SB - 5/5 33

The map of hadrontherapy Rome - 14-15.06.07 - SB - 5/5 34

What a patient sees Rome - 14-15.06.07 - SB - 5/5 35

A ganrty for proton therapy Rome - 14-15.06.07 - SB - 5/5 36

A research topic: proton radiography CT gives information on the density of electrons (Hounsfield numbers) CT is commonly used in diagnostics CT is commonly used in conventional radiation therapy to calculate the treatment planning X and MeV gamma rays interact with the electrons CT is used also in proton and ion therapy to calculate the treatment planning but Protons and ions interact with matter through de/dxdx -> density ρ, Z Compton effect is proportional to Z but not the photoelectric effect! Corrections are applied Rome - 14-15.06.07 - SB - 5/5 37

Proton radiography and proton CT Radiography with X-rays Counts the number of photons (attenuation coefficient) Proton radiography Protons with enough energy to penetrate the body Residual range mesurement Rome - 14-15.06.07 - SB - 5/5 38

Proton radiography Scintillating fibers Advantages No need for corrections like for X-ray CT Less dose to the patient (every proton brings information!) Disadvantages E. Pedroni et al., PSI Need of large accelerators usually used also for therapy (timing problem) For now it is a research issue (PSI) Rome - 14-15.06.07 - SB - 5/5 39

Carbon ion therapy in Europe 1998 - GSI pilot project (G. Kraft) 200 patients t treated t with carbon ions PET on-beam Rome - 14-15.06.07 - SB - 5/5 40

PET on-beam Simulated from TPS Measurement of the real dose given to the patient Measured Rome - 14-15.06.07 - SB - 5/5 41

HIT University of Heidelberg Carbon ion gantry MAN technology December 2006 Hospital based centre Architects Nickl & Partner, Munich and Heidelberg University Building Authority Project started in 2001 First patient treatment foreseen in 2007 Rome - 14-15.06.07 - SB - 5/5 42

The TERA Foundation Not-for-profit foundation created in 1992 by Ugo Amaldi and recognized by the Italian Ministry of Health in 1994 Research in the field of particle accelerators and detectors for hadron-therapy First goal: the Italian National Centre (CNAO) now under construction in Pavia Ugo Amaldi Rome - 14-15.06.07 - SB - 5/5 43

CNAO on the Pavia site Main source of funds: Italian Health Ministry Ground breaking: March 2005 25 m PIMMS/TERA Hospital based centre Design Protons and carbon ions Rome - 14-15.06.07 - SB - 5/5 44

CNAO synchrotron hall in March 2007 Courtesy Sandro Rossi, Fondazione CNAO Rome - 14-15.06.07 - SB - 5/5 45

Neutrons in cancer therapy Rome - 14-15.06.07 - SB - 5/5 46

Hadrontherapy with fast neutrons Berkeley, 1938 Neutrons are neutral no Bragg peak MeV neutrons are produced with cyclotrons (p + Be reaction) MeV neutrons produce nuclear interactions high LET radiation Used for radio resistant tumours (ex. salivary glands, tongue, brain) About 9 centers in the world [ex. Orleans (France), Fermilab (USA)] Rome - 14-15.06.07 - SB - 5/5 47

Boron Neutron Capture Therapy (BNCT) Concept proposed in 1936 by G.L. Locher (only 4 years after the discovery of the neutron!) Bring into cancer cells a nuclide that captures neutrons and disintegrates into high LET fragments 10 B is used Available (20% of natural B) Fragments of high LET and path lengths approximately one cell diameter (about 12 microns) Well known chemistry Rome - 14-15.06.07 - SB - 5/5 48

BNCT facilities Nuclear reactors or accelarators are used as sources of epithermal neutrons Many centers in the world, mostly for clinical trials Limitation Difficult to achieve selective localization in the tumour! Rome - 14-15.06.07 - SB - 5/5 49

End of part V Rome - 14-15.06.07 - SB - 5/5 50